5[5]Rajkumar SV,Fonseca R,Witzig TE,et al.Bone manrrow angiogensis in patients achieving complete response after stem cell transplantation for multiple myeloma[J].Leukemia,1999,13(3):469-472.
6[6]Vacca A,Ribatti D,Preta M,et al.Bone marrow neovaacularization,plasma cell angiogenic potential,and matri me-talloproteinase-2 seretion parallel prngyession of human multiple myeloma[J].Blood,1999,93(9):3064-3073.
7[7]Dankbar B,Pafro T,Leo R,at al.Vaacudar endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma[J].Blood,2000,95(8):2630-2636.
8[8]Singhal S,Mrhta J,Drskan R,et al.Antitumor activity of thalidomide in refractory multiple myeloma[J].N Engl J Med,1999,341(21):1565-1571.
9[9]Rajkumar SV,Kyle RA.Angiogenesis in multiple myeioma[J].Semin Oncol,2001,28(6):560-564.
10[10]Kneller A,Raanani P,Harden I,et al.Therapy with thalidomide in refrsctory multiple myeloma patients the revival of an old drug[J].Br J Haematel,2000,108(2):391-393.
二级参考文献26
1Barlogie B, Zangari M, Spencer T, et al. Thalidomide in the management of multiple myeloma. Semin Hematol, 2001,38:250-259.
2Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med,1999,341:1565-1571.
3Rajkumar S V, Kyle R A. Angiogenesis in multiple myeloma. Semin Oncol, 2001,28:560-564.
4Kneller A, Raanani P, Hardan I,et al. Therapy with thalidomide in refractory multiple myeloma patientsthe revival of an old drug. Br J Haematol, 2000,108:391-393.
5Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med, 1999; 341:1565 - 1571
6Kishi Y, Oki Y, Machida U. Thalidomide in multiple myeloma. N Engl J Med, 2000; 342:975 - 976
7Rhodes EG, Olive C, Flynn MP. A serum-free culture method for myeloma progenitors in vitro: proliferative and immunophenotypic characteristics. Exp Hematol, 1990; 18:79- 83
8Birch JR, Boraston RC, Metcalfe H, et al. Selecting and designing cell lines for improved physiological characteristics. Cytotechnology,1994; 15:11- 16
9杨贵贞.《免疫生物工程与技术》吉林:吉林科学技术出版社,1991年
10Kneller A, Raanani P, Hardan I, et al. Therapy with thalidomide in refractory multiple myeloma patients-the revival of an old drug. Br J Haematol, 2000; 108:391-393
